Inhibition of cell growth and bcl-2 expression in aggressive B-cell lymphomas by retinoic acid.

被引：0
|
作者：
Sundaresan, A
Claypool, CK
LopezBerestein, G
Cabanillas, F
Ford, RJ
机构：
[1] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT PATHOL,HOUSTON,TX 77030
[2] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT MED,HOUSTON,TX 77030
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2400 / 2400
页数：1
相关论文
共 50 条
  • [1] Targeting BCL-2 in B-cell lymphomas
    Davids, Matthew S.
    BLOOD, 2017, 130 (09) : 1081 - 1088
  • [2] BCL-2 GENE REARRANGEMENTS IN MALIGNANT B-CELL LYMPHOMAS
    GRIESSER, H
    LENNERT, K
    BRITISH JOURNAL OF HAEMATOLOGY, 1990, 75 (01) : 142 - 143
  • [3] A targeted molecular classifier of MYC activity and BCL-2 expression in aggressive B-cell lymphomas, designed for clinical practice
    Carey, Christopher D.
    Gusenleitner, Daniel
    Chapuy, Bjoern
    Sun, Heather
    Ligon, Azra
    Kovach, Alexandra E.
    Le, Long P.
    Sohani, Aliyah R.
    Shipp, Margaret
    Monti, Stefano
    Rodig, Scott J.
    CANCER RESEARCH, 2014, 74 (19)
  • [4] Bcl-2 and bax protein expression in indolent versus aggressive B-Cell non-Hodgkin's lymphomas
    Wheaton, S
    Netser, J
    Guinee, D
    Rahn, M
    Perkins, S
    HUMAN PATHOLOGY, 1998, 29 (08) : 820 - 825
  • [5] Changes in Bcl-2 and p53 expression in recurrent B-cell lymphomas
    Ilyas, M
    Kendall, M
    Jalal, H
    Linton, C
    Rooney, N
    JOURNAL OF PATHOLOGY, 1996, 180 (03): : 249 - 253
  • [6] THE BCL-2 GENE IS REARRANGED IN MANY DIFFUSE B-CELL LYMPHOMAS
    AISENBERG, AC
    WILKES, BM
    JACOBSON, JO
    BLOOD, 1988, 71 (04) : 969 - 972
  • [7] Aggressive B-cell lymphomas
    Yang, W
    Listinsky, CM
    UPDATES IN DIAGNOSTIC PATHOLOGY, 2005, 563 : 125 - 134
  • [8] Retinoid-mediated inhibition of cell growth with stimulation of apoptosis in aggressive B-cell lymphomas
    Sundaresan, A
    Claypool, K
    Mehta, K
    LopezBerestein, G
    Cabanillas, F
    Ford, RJ
    CELL GROWTH & DIFFERENTIATION, 1997, 8 (10): : 1071 - 1082
  • [9] Expression of the NF-κB targets BCL2 and BIRCS/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively
    Tracey, L
    Pérez-Rosado, A
    Artiga, MJ
    Camacho, FI
    Rodríguez, A
    Martínez, N
    Ruiz-Ballesteros, E
    Mollejo, M
    Martinez, B
    Cuadros, M
    Garcia, JF
    Lawler, M
    Piris, MA
    JOURNAL OF PATHOLOGY, 2005, 206 (02): : 123 - 134
  • [10] Immunotherapy in aggressive B-cell lymphomas
    Jacobson, Caron A.
    Armand, Philippe
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2018, 31 (03) : 299 - 305
12345